Italy · 
Who invested in Resalis Therapeutics?
Resalis Therapeutics's investors include Sanofi, Italian Angels for Growth and Club degli Investitori.
Italy · Venture startup
Who invested in Resalis Therapeutics
Funding summaryUpdated 26 Oct 2026
Undisclosedraised across 1 round since 2024, from 1 source
- Latest round
- VentureOct 2024
- Investors
- 3
The rounds
- Oct 2024
Founders and team
From Resalis Therapeutics's own website: 2 founders, 13 on the team.
- Alessandro TonioloChief Executive Officer
- Almut NitscheChief Development Officer
- Diana M. RøpckeChief Medical Officer
- Thomas EichingerChief Technical Development Officer
- Anna AltieriTranslational Research Lead
- Arianna CuomoPreclinical Research Associate
- Claus AnderssonNon-Executive Director
- Giulia GrilloPreclinical Research Associate
- Halina NovakNon-Executive Director
- Pietro PuglisiChairman
- Sandor BatkaiMedical Director
- Valentina AgnolonDevelopment Lead
- Valentina GaudioBusiness Analyst
Everyone who backed them
Italian Angels for GrowthVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Resalis Therapeutics
How much has Resalis Therapeutics raised?
Resalis Therapeutics has raised 1 round since 2024, none with a disclosed amount.
When did Resalis Therapeutics last raise?
Resalis Therapeutics's most recent round was a Venture in Oct 2024.
Who backed Resalis Therapeutics first?
Resalis Therapeutics's first round on record, in Oct 2024, was backed by Sanofi, Italian Angels for Growth and Club degli Investitori.
What stage is Resalis Therapeutics at?
Resalis Therapeutics's latest named round is a Venture, in Oct 2024.
Where is Resalis Therapeutics based?
Resalis Therapeutics is based in Italy.
Companies like Resalis Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.